Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism
Condition(s):Secondary HyperparathyroidismLast Updated:February 9, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Secondary HyperparathyroidismLast Updated:February 9, 2024Recruiting
Condition(s):Secondary HyperparathyroidismLast Updated:November 30, 2023Recruiting
Condition(s):Secondary HyperparathyroidismLast Updated:July 23, 2020Completed
Condition(s):Secondary Hyperparathyroidism; Myocardial DysfunctionLast Updated:January 3, 2024Completed
Condition(s):Secondary HyperparathyroidismLast Updated:March 5, 2015Completed
Condition(s):Chronic Kidney Disease; Secondary HyperparathyroidismLast Updated:September 15, 2014Completed
Condition(s):Chronic Kidney Disease, Secondary HyperparathyroidismLast Updated:July 10, 2019Completed
Condition(s):Secondary HyperparathyroidismLast Updated:June 14, 2022Completed
Condition(s):Secondary HyperparathyroidismLast Updated:June 18, 2023Active, not recruiting
Condition(s):Secondary HyperparathyroidismLast Updated:August 8, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.